Texarkana, TX 86° Thu H 94° L 75° Fri H 93° L 77° Sat H 92° L 74° Weather Sponsored By:

On the Money: Some options to cut costs for diabetics

On the Money: Some options to cut costs for diabetics

April 15th, 2019 by Associated Press in Features

A woman with Type 2 diabetes prepares to inject herself with insulin on April 18, 2017, at her home in Las Vegas. The skyrocketing price of insulin has some diabetics scrambling to cover the cost of the life-saving medication. Others are skipping doses or using smaller amounts than needed, and sometimes landing in the ER, patients and advocates recently told Congress.

Photo by Associated Press /Texarkana Gazette.

TRENTON, N.J.—The skyrocketing price of insulin has some diabetics scrambling to cover the cost of the life-saving medication.

Others are skipping doses or using smaller amounts than needed, and sometimes landing in the emergency room, patients and advocates told Congress recently.

About 7.4 million Americans use insulin to keep their blood sugar at safe levels. Insulin needs vary by patient, as do costs depending on insurance coverage.

Amid the public uproar about costs, drugmakers and some prescription plans are starting to offer patients bigger discounts. Express Scripts and its parent company, insurer Cigna, just began offering a month's worth of insulin to eligible patients for $25 per month. Express Scripts is now lining up other insurers whose prescription plans it manages.

For most insulin and other diabetes medicines, manufacturers offer coupons reducing monthly out-of-pocket costs.

The American Diabetes Association connects patients to assistance programs through www.insulinhelp.org , though not everyone qualifies.

"We do not want anyone to skip or ration doses," says Dr. William Cefalu, the advocacy group's chief scientific officer.

If you are struggling to afford insulin, tell your doctors, says Cefalu. They might be able to recommend a free clinic or patient assistance plan, or suggest cheaper options.

If cost is an issue, here are other ways to save money:



Talk to your doctor about switching to older, cheaper kinds of insulin, suggests Dr. Robert Gabbay, chief medical officer at Joslin Diabetes Center in Boston. Dangerous blood sugar plunges are more common with those, as they don't control blood sugar as tightly as newer, more expensive insulins. Patients using older products such as Novolin and Humulin R must test their blood sugar more often, and more carefully time when they inject insulin before meals, Gabbay stresses.



Patients who've been using insulin pens—injection devices containing multiple insulin doses—could switch to insulin vials. They are cheaper but less convenient. It requires drawing insulin out of the vial into a syringe, which makes doses less precise, and the abdominal injections hurt a bit more. Another option is Basaglar, a cheaper near-copy of the popular long-acting Lantus insulin pens.



Review your insurance company's list of covered medications for insulin with the lowest copayments; coverage and copayments often change in January and there may be cheaper choices. Other savings options include getting a 90-day supply instead of 30-day refills.



Check prices at different pharmacies. Prices can vary widely for insulin, other diabetes drugs and the testing strips and lancets needed to check blood sugar levels. Patients can look up drug prices at multiple drugstores and get coupons for big discounts at the pharmacy counter at www.GoodRx.com . Or try www.healthwarehouse.com , which sells medicines at cash prices, which can be cheaper even if you have insurance.

Medicare and Medicaid patients can't combine coupons with their insurance, but a coupon alone might be the cheapest option.

The three main insulin makers offer savings, including:

n Sanofi's Insulins ValYOU Savings Program offers uninsured and cash-paying patients one insulin vial for $99 or one insulin pen for $149 each month. Starting in June, it will offer up to 10 vials and/or pens of most of its insulins for $99. Its Sanofi Patient Connection offers low-income uninsured patients free insulin.

n Eli Lilly will soon sell Insulin Lispro, a half-price version of its top-selling insulin Humalog KwikPens, for $265 per month. Its Lilly Diabetes Solution Center helps patients find affordable options.

n Novo Nordisk has long sold an older insulin, ReliOn, through Walmart for about $25 a vial. It's now available through CVS Health and Express Scripts. Novo Nordisk offers copay savings cards for Tresiba and other insulins, plus patient assistance with generous income limits at www.NovoCare.com.

Getting Started/Comments Policy

Getting started

  1. 1. If you frequently comment on news websites then you may already have a Disqus account. If so, click the "Login" button at the top right of the comment widget and choose whether you'd rather log in with Facebook, Twitter, Google, or a Disqus account.
  2. 2. If you've forgotten your password, Disqus will email you a link that will allow you to create a new one. Easy!
  3. 3. If you're not a member yet, Disqus will go ahead and register you. It's seamless and takes about 10 seconds.
  4. 4. To register, either go through the login process or just click in the box that says "join the discussion," type your comment, and either choose a social media platform to log you in or create a Disqus account with your email address.
  5. 5. If you use Twitter, Facebook or Google to log in, you will need to stay logged into that platform in order to comment. If you create a Disqus account instead, you'll need to remember your Disqus password. Either way, you can change your display name if you'd rather not show off your real name.
  6. 6. Don't be a huge jerk or do anything illegal, and you'll be fine.

Texarkana Gazette Comments Policy

The Texarkana Gazette web sites include interactive areas in which users can express opinions and share ideas and information. We cannot and do not monitor all of the material submitted to the website. Additionally, we do not control, and are not responsible for, content submitted by users. By using the web sites, you may be exposed to content that you may find offensive, indecent, inaccurate, misleading, or otherwise objectionable. You agree that you must evaluate, and bear all risks associated with, the use of the Gazette web sites and any content on the Gazette web sites, including, but not limited to, whether you should rely on such content. Notwithstanding the foregoing, you acknowledge that we shall have the right (but not the obligation) to review any content that you have submitted to the Gazette, and to reject, delete, disable, or remove any content that we determine, in our sole discretion, (a) does not comply with the terms and conditions of this agreement; (b) might violate any law, infringe upon the rights of third parties, or subject us to liability for any reason; or (c) might adversely affect our public image, reputation or goodwill. Moreover, we reserve the right to reject, delete, disable, or remove any content at any time, for the reasons set forth above, for any other reason, or for no reason. If you believe that any content on any of the Gazette web sites infringes upon any copyrights that you own, please contact us pursuant to the procedures outlined in the Digital Millennium Copyright Act (Title 17 U.S.C. § 512) at the following address:

Copyright Agent
The Texarkana Gazette
15 Pine Street
Texarkana, TX 75501
Phone: 903-794-3311
Email: webeditor@texarkanagazette.com